Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Other-Operating-Expenses" stands at 0.2827 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 12/31/2023.
Sino Biopharmaceutical Ltd's second quarter result of -1E-6 Billion HKD for the item "Other Operating Expenses" represents no change compared to it's first quarter result.
Also, Sino Biopharmaceutical Ltd's second quarter result of -1E-6 Billion HKD for the item "Other Operating Expenses" represents a decrease of -107,520.00 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sino Biopharmaceutical Ltd's second quarter result of 0.2827 Billion HKD for the item "Other Operating Expenses" represents a decrease of -4E-4 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -1.39 Billion Hong Kong Dollars compared to the value the year prior.
The 1 year change is -1.39 Billion Hong Kong Dollars.
The 3 year change is -0.3768 Billion Hong Kong Dollars.
The 5 year change is 1.04 Billion Hong Kong Dollars.
The 10 year change is 0.6395 Billion Hong Kong Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Operating Expenses | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Operating Expenses | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Operating Expenses | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Operating Expenses | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Operating Expenses | 280,205,508,085.11 |